U.S. Wireless Telecom Stock News

NYSE:XOM
NYSE:XOMOil and Gas

Is ExxonMobil Holdings (XOM) Still Below Fair Value As Oil Tops $80?

ExxonMobil Holdings has delivered a very strong 223.0% return over the past 5 years, yet current checks suggest the stock may still trade below an intrinsic value estimate built from a Discounted Cash Flow (DCF) model and supported by earnings based multiples. That combination puts the focus on whether the recent strength in ExxonMobil’s share price has fully reflected the cash flows investors expect from its oil and gas business. A 223.0% 5 year return signals that ExxonMobil has already...
NasdaqGS:LKFN
NasdaqGS:LKFNBanks

Lakeland Financial (LKFN) Stock Faces Premium P/E As 40.6% Net Margin Reinforces Bullish Narratives

Lakeland Financial (LKFN) has put up another solid quarter, with Q2 2026 revenue of US$69.2 million and basic EPS of US$1.13, backed by trailing 12 month net income of US$111.2 million and EPS of US$4.37 that reflect the 17.6% earnings growth cited over the past year. The company has seen revenue move from US$239.4 million to US$273.7 million on a trailing 12 month basis, while net income has shifted from US$94.6 million to US$111.2 million over the same period. This gives investors a clear...
NasdaqGS:HOPE
NasdaqGS:HOPEBanks

Hope Bancorp (HOPE) Stock Faces Bullish Narratives As Net Margin Reaches 23.9% In Q2 2026

Hope Bancorp (HOPE) opened Q2 2026 with total revenue of US$138.5 million and basic EPS of US$0.26, supported by trailing 12 month EPS of about US$1.00 on revenue of US$534.0 million and net income of US$127.8 million. Over recent quarters the company has seen revenue move from US$77.1 million in Q2 2025 to US$139.4 million in Q4 2025 and US$129.9 million in Q1 2026. EPS shifted from a loss of US$0.22 in Q2 2025 to US$0.29 in Q4 2025 and US$0.23 in Q1 2026, setting up this latest print as...
NasdaqGS:BMRC
NasdaqGS:BMRCBanks

Bank Of Marin Bancorp (BMRC) Stock Faces Turnaround Test After Back To Back Quarterly Profits

Bank of Marin Bancorp (BMRC) opened Q2 2026 with total revenue of about US$34.3 million and basic EPS of US$0.58, providing a clear snapshot of the bank’s current income statement. The company’s revenue moved from US$30.9 million in Q3 2025 to US$33.7 million in Q1 2026 and then to US$34.3 million in Q2 2026. Over the same period, basic EPS shifted from US$0.47 to US$0.53 and then to US$0.58, giving investors a concrete view of recent earnings power as they consider the tension between...
NYSE:KOF
NYSE:KOFBeverage

Coca-Cola FEMSA (NYSE:KOF) Stock Faces Slower 1.5% Earnings Growth Testing Bullish Narrative

Coca-Cola FEMSA (NYSE:KOF) has reported Q2 2026 revenue of about MX$76.3b and basic EPS of MX$4.73, with trailing twelve month EPS at MX$18.24 on revenue of roughly MX$296.2b, setting the tone for this earnings season update. The company has seen quarterly revenue move from about MX$72.3b and EPS of MX$25.27 in Q2 2025 to MX$76.3b and MX$4.73 in Q2 2026. Trailing twelve month revenue has shifted from roughly MX$288.0b with EPS of MX$48.56 to MX$296.2b and MX$18.24, giving investors a clearer...
NasdaqGS:ARLP
NasdaqGS:ARLPOil and Gas

Alliance Resource Partners (ARLP) Stock Faces 9.36% Dividend Coverage Strain After Q2 2026 Earnings

Alliance Resource Partners (ARLP) has put fresh numbers on the table for Q2 2026, reporting revenue of US$551.6 million and basic EPS of US$0.62, supported by trailing twelve month EPS of US$2.05 and a trailing net margin of 12.1% compared with 10.2% a year earlier. The company has seen quarterly revenue move around the US$516 million to US$571 million range over the last six reported periods, while basic EPS has ranged from US$0.07 to US$0.73. This sets the backdrop for the current print and...
NYSE:CMRE
NYSE:CMREShipping

Costamare (CMRE) Stock Faces Margin Weakness As Long‑Term Contract Story Is Tested

Costamare (NYSE:CMRE) has reported Q2 2026 revenue of US$209.2 million and basic EPS of US$0.64, alongside trailing 12 month EPS of US$2.64 on revenue of US$857.4 million. This gives investors a clear view of the latest run rate. Over the past few quarters, revenue has moved from US$217.9 million and EPS of US$0.83 in Q2 2025 to US$209.2 million and EPS of US$0.64 in Q2 2026 as margins have shifted and filtered through to the trailing figures. With net margin on the trailing 12 month basis...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Berkshire Hathaway (BRK.A) Completes $4.1 Billion Taylor Morrison Deal And Expands Homebuilding

Berkshire Hathaway (NYSE:BRK.A) has completed its US$4.1b acquisition of homebuilder Taylor Morrison. The deal expands Berkshire Hathaway's US residential homebuilding operations through integration with its existing site built division. Completion of the transaction makes Berkshire Hathaway the fourth largest homebuilder in the United States. Berkshire Hathaway is already active in residential construction through Clayton Properties Group and other housing related businesses, and Taylor...
NasdaqGS:BSRR
NasdaqGS:BSRRBanks

Sierra Bancorp (BSRR) Stock EPS Holds Firm And Reinforces Profitability Focus Narrative

Sierra Bancorp (BSRR) has just posted its Q2 2026 numbers, reporting revenue of US$36.8 million and EPS of US$0.77. Trailing twelve month revenue of US$151.8 million and EPS of US$3.44 help frame the latest quarter within a steadier multi quarter run rate. Over the past year, the company has reported revenue moving from US$145.4 million to US$151.8 million and EPS from US$2.92 to US$3.44, providing context for how investors may interpret the current results. With net income at US$9.9 million...
NYSE:NEE
NYSE:NEEElectric Utilities

NextEra Energy (NEE) Moves Closer To Dominion Merger As Virginia Review Begins

NextEra Energy (NYSE:NEE) is moving ahead with its planned merger with Dominion Energy, targeting closure by late 2027 as regulatory review begins, including an upcoming Virginia hearing. The company is also expanding into large-scale gas-fired generation hubs while joining the White House Ratepayer Protection Pledge related to AI data center grid investments. The pledge aims to limit the extent to which AI-related infrastructure costs are passed on to retail customers, a key issue for...
NYSE:FHN
NYSE:FHNBanks

AI-Centric Leadership Hires and Solid Q2 Results Could Be A Game Changer For First Horizon (FHN)

First Horizon Corporation recently appointed Scott Serpico as Senior Vice President, Head of Product, and Catherine Wood as Senior Vice President, Head of Commercial Banking Strategy, while also reporting second-quarter 2026 net income of US$271 million and basic earnings per share from continuing operations of US$0.55. These leadership moves concentrate on expanding products and embedding AI and technology across commercial banking, highlighting management’s emphasis on product innovation...
NYSE:JXN
NYSE:JXNDiversified Financial

Leadership Shuffle at Jackson Financial (JXN) Could Be A Game Changer For Its Risk Discipline

Jackson Financial Inc. has outlined a leadership transition, with CEO Laura L. Prieskorn retiring on September 30, 2026, and current CFO Don W. Cummings becoming CEO, President, and a director, while long-time executive Brian M. Walta steps into the roles of Executive Vice President and Chief Financial Officer on October 1, 2026. This internal succession plan, elevating experienced finance and risk leaders from within Jackson’s existing ranks, signals an emphasis on continuity in capital...
NYSE:PATH
NYSE:PATHSoftware

UiPath (PATH) Stock Has Weak Returns But Cash Flow Looks Strong

UiPath stock has fallen about 82% over the past five years. Current valuation checks suggest the shares now trade at a discount to what the company’s cash flows may justify, creating a clear tension between a weak long term return profile and an intrinsic value estimate that points to upside. Over five years, UiPath shareholders have seen the stock decline around 82%. This puts the recent valuation debate in the context of a long period of weak returns. The recent AI driven pricing contract...
NasdaqGS:CASH
NasdaqGS:CASHBanks

How Lower Income, New EPS Targets and Credit Probes At Pathward Financial (CASH) Has Changed Its Investment Story

On July 22, 2026, Pathward Financial, Inc. reported lower quarterly net interest income of US$112.91 million and net income of US$28.97 million, updated its fiscal 2026 EPS guidance to US$7.80–US$8.20, introduced 2027 EPS guidance of US$9.50–US$10.00, and detailed completion of a share repurchase totaling 3,872,821 shares for US$303.85 million. A securities law firm has since opened an investigation into Pathward’s disclosures around rising nonperforming loans and renewable energy...
NasdaqGS:CVBF
NasdaqGS:CVBFBanks

Is CVB Financial (CVBF) Cheap After Mixed Earnings Signals?

Mixed earnings signals at CVB Financial CVB Financial (CVBF) recently reported second quarter and six month results that combined higher net interest income with slightly lower net income and earnings per share, giving investors a mixed picture of profitability and growth. See our latest analysis for CVB Financial. Against this latest earnings release and the recent board appointment of Michael J. Maddox, CVB Financial's recent momentum is positive, with a 10.10% 90 day share price return and...
NYSE:PBI
NYSE:PBICommercial Services

Pitney Bowes (PBI) Could Be 4% Overvalued As New Board Appointment Draws Focus

Pitney Bowes (PBI) drew investor attention after appointing La Vonda Williams to its Board of Directors, adding nearly two decades of finance and operations experience to the company’s recently formed Strategic Review Committee. See our latest analysis for Pitney Bowes. The recent appointment to Pitney Bowes' Strategic Review Committee comes after a period where momentum has shifted, with a 73.09% year to date share price return and a very large 3 year total shareholder return of 405.45%...
NasdaqGS:SIGI
NasdaqGS:SIGIInsurance

Is Selective Insurance Group (SIGI) Undervalued On Strong Q2 Results?

Why Selective Insurance Group Stock Is Back on Investors’ Radar Selective Insurance Group (SIGI) moved into focus after reporting second quarter 2026 results that included higher revenue and net income, along with continued dividends and share repurchases that highlight current capital return priorities. See our latest analysis for Selective Insurance Group. At a share price of $96.33, Selective Insurance Group has seen a 12.52% 90 day share price return and a 25.33% 1 year total shareholder...
NYSE:RBA
NYSE:RBACommercial Services

Is RB Global's Higher Dividend Shaping a New Capital Allocation Story for RBA?

RB Global, Inc. previously announced that on July 21, 2026, its Board of Directors declared a quarterly cash dividend of US$0.33 per common share, payable on September 17, 2026 to shareholders of record on August 25, 2026, and classified as an eligible dividend for Canadian income tax purposes. This dividend decision highlights the company’s ongoing cash returns to shareholders while it continues to operate global marketplaces for commercial assets and vehicles under brands such as Ritchie...
NYSE:FR
NYSE:FRIndustrial REITs

First Industrial Realty Trust (FR) Reports Strong Earnings, Is The Stock Fully Valued?

First Industrial Realty Trust (FR) has drawn fresh attention after reporting second quarter 2026 earnings, with sales of US$194.94 million and net income of US$77.1 million, alongside updated half-year results. See our latest analysis for First Industrial Realty Trust. At a share price of US$66.99, First Industrial Realty Trust has posted a 5.36% 30 day share price return and a 15.70% year to date share price return, while the 1 year total shareholder return of 41.89% points to momentum that...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

GeneDx Stock And 2 Testing Companies In Focus After Cyclospora Outbreak

The recent Cyclospora outbreak has pushed food safety, traceability, and testing to the top of investors’ watchlists. When regulators, distributors, and restaurant suppliers come under pressure, attention often shifts to companies that help monitor, test, and verify what moves through the food supply chain. This article looks at how that news may affect a handful of Food Safety & Testing Companies, and why some stocks could be positioned as potential beneficiaries of higher scrutiny and...
NasdaqGS:PECO
NasdaqGS:PECORetail REITs

Stronger Q2 Earnings And Raised Guidance Could Be A Game Changer For Phillips Edison (PECO)

In July 2026, Phillips Edison & Company reported second-quarter revenue of US$189.62 million and net income of US$41.12 million, alongside higher earnings per share versus a year earlier, and raised its 2026 diluted net income guidance to US$0.95–US$0.97 per share from US$0.79–US$0.81. The combination of higher current-period profits and an upward revision to full-year earnings guidance highlights management’s increased confidence in the company’s operating performance. With this stronger...
NYSE:ATEN
NYSE:ATENSoftware

US Tech Stocks Retail Investors May Find More Sheltered From EU Rules And Tariffs

Renewed EU regulation and tariff threats are putting global tech stocks under a spotlight, while many US domestic focused technology companies sit slightly to one side of the crossfire. For investors sorting through the noise, the question is which stocks appear more insulated from these trade and regulatory headlines and which still carry meaningful exposure. This article examines how the latest EU actions and US tariff rhetoric could affect sentiment around certain US tech companies, and...
NasdaqCM:NKTR
NasdaqCM:NKTRPharmaceuticals

Is Nektar Therapeutics (NKTR) Undervalued On Its Phase 3 Rezpegaldesleukin Launch?

Nektar Therapeutics (NKTR) has launched the first two global Phase 3 ZENITH AD trials for rezpegaldesleukin in moderate to severe atopic dermatitis, supported by earlier Phase 2b data and FDA Fast Track designations. See our latest analysis for Nektar Therapeutics. The latest rezpegaldesleukin Phase 3 launch comes after a sharp shift in sentiment around Nektar Therapeutics, with a 1-year total shareholder return of 199.05% and a year to date share price return of 62.89%. However, momentum has...
NYSE:QGEN
NYSE:QGENLife Sciences

Is Qiagen (QGEN) A Bargain On Its Infectious Disease Testing Push?

Qiagen (QGEN) is back in focus after highlighting its molecular testing tools in the U.S. cyclosporiasis response and launching a CE-IVDR-certified bloodstream infection and antimicrobial resistance panel for its QIAstat-Dx platform in Europe. See our latest analysis for Qiagen. Qiagen’s recent focus on infectious disease diagnostics comes as the stock trades at US$41.37, with a 90 day share price return of 21.6% but a year to date share price return that is down 13.03%, and a 1 year total...